he safety of long‐term PPI use in pediatric patients has not been well understood. A recent review by De Bruyne and Ito indicated that PPI are associated with increased risks of gastrointestinal and respiratory tract infection, vitamin B12 deficiency, hypomagnesemia, bone fracture, and rebound hyperacidity after discontinuation.
No comments:
Post a Comment